{"name": "Asterion",
 "permalink": "asterion",
 "crunchbase_url": "http://www.crunchbase.com/company/asterion",
 "homepage_url": "http://www.asterion.co.uk",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "richardross@asterion.co.uk",
 "phone_number": "0114-275-5555",
 "description": "",
 "created_at": "Mon May 03 03:35:27 UTC 2010",
 "updated_at": "Mon May 03 03:43:12 UTC 2010",
 "overview": "\u003Cp\u003EAsterion is to design and develop superior, patient-friendly drugs for the treatment of serious chronic and acute disorders. Their patented technologies and products offer the promise of long-acting potent biopharmaceuticals that will require less frequent administration than existing marketed drugs. These products have the potential to improve healthcare outcomes and offer other potential benefits in terms of efficacy, side effect profile, compliance and manufacture.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       39],
      "assets/images/resized/0008/5699/85699v1-max-150x150.jpg"],
     [[250,
       65],
      "assets/images/resized/0008/5699/85699v1-max-250x250.jpg"],
     [[274,
       72],
      "assets/images/resized/0008/5699/85699v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$678k",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 678000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 5,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Spirit Capital Partners",
         "permalink": "spirit-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               105],
              "assets/images/resized/0007/1563/71563v1-max-150x150.jpg"],
             [[173,
               122],
              "assets/images/resized/0007/1563/71563v1-max-250x250.jpg"],
             [[173,
               122],
              "assets/images/resized/0007/1563/71563v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fusion IP",
         "permalink": "fusion-ip",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0009/9992/99992v1-max-150x150.jpg"],
             [[250,
               61],
              "assets/images/resized/0009/9992/99992v1-max-250x250.jpg"],
             [[284,
               70],
              "assets/images/resized/0009/9992/99992v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "The Innovation Centre",
    "address2": "217 Portobello",
    "zip_code": "S1 4DP",
    "city": "Sheffield",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        102],
       "assets/images/resized/0008/5700/85700v1-max-150x150.jpg"],
      [[250,
        170],
       "assets/images/resized/0008/5700/85700v1-max-250x250.jpg"],
      [[450,
        306],
       "assets/images/resized/0008/5700/85700v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}